Amalgamated Bank’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
VCM
MG
IHAM
Amalgamated Bank's SANA Position: Q1 2026 in Review
Amalgamated Bank sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 5,190 shares — an estimated $21K sold.
Amalgamated Bank first reported a position in SANA in Q3 2021 and held it in 18 quarters. The position peaked at $327K in Q3 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.
- Amalgamated Bank reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 5,190 Sana Biotechnology shares in Q1 2026, an estimated $21K.
- Amalgamated Bank first reported a position in Sana Biotechnology in Q3 2021 and held it in 18 quarters.
- Amalgamated Bank's Sana Biotechnology position peaked at $327K in Q3 2021.
- 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.